Immucor (BLUD) Tops Q1 EPS by 5c; Reaffirms Forecast
More News related to BLUD
- Immucor to Present at the Piper Jaffray 21st Annual Health Care Conference
- The Pomerantz Firm Charges Immucor, Inc. With Securities Fraud -- BLUD
- After-Hours Movers 10/01: TELK, ONCY, QLTI, BLUD, FSLR Higher; GRT, RECN, SMOD, ACN, NCT, KEG Lower
- Immucor (BLUD) Tops Q1 EPS by 5c; Reaffirms Forecast
- Immucor Announces Fiscal First Quarter Results
Immucor (Nasdaq: BLUD) reports Q1 EPS of $0.30, 5 cents better than the analyst estimate of $0.25. Revenue for the quarter was $83.1 million, which compares to the estimate of $77.83 million.
Immucor also reaffirms its forecast.
Related Categories
EarningsGuidance
Stocks Mentioned
-0.38Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
